ADVERTISEMENT

ADVERTISEMENT

Brief Overview of The Trianni Mouse Platform

TRIANNIs antibody discovery platform, The Trianni Mouse, represents best-in-class technology for efficient generation of fully-human monoclonal antibodies.

TRIANNIs antibody discovery platform, The Trianni Mouse, represents best-in-class technology for efficient generation of fully-human monoclonal antibodies.

For further information please click here: http://www.trianni.com

© european biotechnology

6 March 2018

YOU MIGHT ALSO LIKE

Science, www.science.org/doi/10.1126/sciadv.adn8662

Environmental research

Breakthrough: Bio-based foam absorbs 99% o...

Chinese researchers headed by Prof. Dr. Hongbing Deng from Wuhan University report the were able to absorb up to 99.9% of microplastics in water, which could help solve one of the most pressing environmental … more ➔

Cradle Secures $73m Series B to Accelerate...

The Dutch-Swiss company with operations also in Zurich, Switzerland, has raised US$73m in a Series B and will continue to expand its AI research, sales, and operations teams. The new announcement comes … more ➔

Roche, Herzog&De Meuron

Roche makes takeover bid for Poseida Thera...

Genentech, the US arm of Swiss-based Roche AG, plans to acquire its long-time partner in allogeneic CAR-T blood cancer and gene therapies, Poseida Therapeutics Inc, for up to US$1.5bn. more ➔

YOU DON`T WANT TO MISS ANYTHING?

Sign up for our newsletter!